non-familial hypercholesterolaemia
Cardiovascular · 2019–2019
1decision
1medicine
1carried consumer input
6individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| alirocumab Treatment of heterozygous familial hypercholesterolaemia (he-FH) with high cardiovascular risk (patients with atherosclerotic disease and/or very high LDL… | Mar 2019 | Recommended with restriction | 6 individuals Familial Hypercholesterolaemia Family Support Group |
Who spoke
Familial Hypercholesterolaemia Family Support Group
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 1 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.